Exchange: NASDAQ·Updated 07:34 PM EDT
ORGO logo

ORGOOrganogenesis Holdings Inc - Ordinary Shares - Class A

$2.39
$0.04
(1.65%)
Today
Closed $2.39
$0.00
(0.00%)
After Hours
EarningsAug 6
Mkt Cap$307.53M
Vol1.18M
News
all
press releases
The Body as Blueprint: A Recently Public Biotech Bets That Regrown Tissue Beats Replacement Parts
The Body as Blueprint: A Recently Public Biotech Bets That Regrown Tissue Beats Replacement Parts The Body as Blueprint: A Recently Public Biotech Bets That Regrown Tissue Beats Replacement Parts PR Newswire TAMPA, Fla., June 2, 2026 Issued on behalf of Conexeu Sciences Inc.A newly listed...
PR Newswire
More News
Organogenesis (ORGO) Projected to Post Earnings on Thursday
Organogenesis (NASDAQ:ORGO) will be releasing its Q1 2026 earnings after the market closes on Thursday, May 7. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-7-organogenesis-holdings-inc-stock...
MarketBeat
Organogenesis (NASDAQ:ORGO) Trading Up 1.7% - Time to Buy?
Organogenesis (NASDAQ:ORGO) Shares Up 1.7% - What's Next...
MarketBeat
ORGO Stock Rallies After Hours On Clearing Regulatory Pathway For Pain Relief Treatment
Organogenesis is seeking approval for ReNu in knee osteoarthritis pain, a degenerative joint disease that is estimated to affect nearly 31.1 million Americans.
Stocktwits
Organogenesis (NASDAQ:ORGO) Receives "Buy" Rating from BTIG Research
BTIG Research reissued a "buy" rating and issued a $8.00 price objective on shares of Organogenesis in a research report on Thursday...
MarketBeat
Assenagon Asset Management S.A. Acquires 680,392 Shares of Organogenesis $ORGO
Assenagon Asset Management S.A. raised its stake in shares of Organogenesis (NASDAQ:ORGO - Free Report) by 14.0% during the fourth quarter, according to its most recent disclosure with the Securities...
MarketBeat
Organogenesis $ORGO Shares Acquired by First Light Asset Management LLC
First Light Asset Management LLC lifted its stake in shares of Organogenesis (NASDAQ:ORGO - Free Report) by 10.6% during the 3rd quarter, according to the company in its most recent filing with the...
MarketBeat
Insider Buying: Organogenesis (NASDAQ:ORGO) Director Buys 5,000 Shares of Stock
Organogenesis (NASDAQ:ORGO - Get Free Report) Director Arthur Leibowitz purchased 5,000 shares of the stock in a transaction on Monday, March 9th. The stock was acquired at an average cost of $2.68...
MarketBeat
Michael Joseph Driscoll Buys 10,000 Shares of Organogenesis (NASDAQ:ORGO) Stock
Organogenesis (NASDAQ:ORGO - Get Free Report) Director Michael Joseph Driscoll purchased 10,000 shares of the business's stock in a transaction on Monday, March 9th. The shares were purchased at an...
MarketBeat
Insider Buying: Organogenesis (NASDAQ:ORGO) Director Buys $13,400.00 in Stock
Organogenesis (NASDAQ:ORGO - Get Free Report) Director Arthur Leibowitz acquired 5,000 shares of the firm's stock in a transaction on Monday, March 9th. The shares were acquired at an average price...
MarketBeat
<
1
2
...
>

Advertisement|Remove ads.